Thursday, October 29, 2026

Build-A-Bear (BBW) Part II: The Scion Capital Analyst Tempate and the All Map

Build-A-Bear’s lease overhaul, off-mall expansion and partner-led wholesale growth reshaped a debt-free retailer with $80 million EBITDA, despite 25% short interest.

BBW $327M

Cassandra Unchained Oct 29 2 clicks

Oct 29 WGO $842M

This Week in Special Situations: Mattel, Winnebago, PayPal

Latticework by MOI Global 3 clicks

Oct 28 DAKT $913M

Daktronics (DAKT): Dominant Leader | Deep Dive

Hidden Gems Investing 6 clicks

From X

@BarbarianCap Sep 21 4 clicks

Barbarian Capital on X

Ethan Allen Launches Search for Next Chief Executive $ETD https://t.co/w9liHmiy2F

@Adam_Wyden Sep 21

Adam D. Wyden on X

@KEDM_COM Pretty sure our most recent letter had liquidation in the mid 30s on 2027 roll fwd…. Stock lower. Nav higher. Insider buying won’t keep them at the controls. $CODI

@ACapitalLP Sep 21

A Capital on X

$WYFI meaningfully lagging the other Powered Shell Providers…. https://t.co/JWZPbrU54S

@finphysnerd Sep 21 1 click

Myles on X

Long some $RSP calls. Breadth is completely washed out and implied vol seems cheap. Seasonality is favourable, feels like an attractive place to be long, and cheap on the options side. https://t.co/00h6Oyvnmk

@KEDM_COM Sep 21

KEDM.com on X

ADW Capital continues to increase its stake in Compass Diversified $CODI, now already reflecting 14%. It's also good to see insiders buying shares on the open market. We flagged CODI a few weeks ago. ADW is pushing for a liquidation, stating that a wind‑down could unlock over $26 p/s, well above the current price. As a reminder, CODI’s share price collapsed last year on the accounting mess at its sub Lugano, forcing CODI to declare its 2022-24 financials unreliable. Lugano had hidden financing arrangements and misstated sales, inventory, and receivables. The fallout pushed CODI into forbearance, dividend suspension, reduced borrowing capacity, and eventually covenant breaches. The company has already questioned its ability to continue as a going concern; i.e., there is a good chance they'll liquidate.

@DOMOCAPITAL Sep 21

DOMO Capital Management, LLC on X

$MNRO must buy all lubricants, non-lubes and service chemicals from Valvoline and can't market competing products. This is an in-depth partnership. Could there be a price increase? Sure, prices have already gone up this year quite a bit, but it won't be the price gouging type of supply that shops with no vendor will be facing. Two main points here. $MNRO is not in danger of running out of supply and if the price does increase, it won't be to the level of competitors without this type of relationship. I had a discussion with a manager at TiresPlus that points to exactly this. Prices so far this year have increased, but he said that the pricing he is getting from vendors he doesn't have a relationship with is multiples higher and he's going to have to pull the trigger with one of them within weeks.

@AsifSuria Sep 21

Asif Suria on X

@Investor_NICK_ @aurelius28 TMS and ketamine made a world of difference to their bottom line. Especially when companies like BrainsWay $BWAY were willing to finance the TMS machines for doctors. https://t.co/Y2bQqX0ALu

@DOMOCAPITAL Sep 21

DOMO Capital Management, LLC on X

And the only reason $MNRO has been hurt is because cost conscious customers have been postponing the services that make all the money (tires, brakes, etc). You can only postpone these items for so long. The demand never goes away.... This is a temporary industry issue and $MNRO is winning market share.

How to Read a 10-K Like a Short Seller

A four-layer 10-K framework tests revenue timing, receivables, reserves and depreciation against cash flow, using Hertz’s 2012-14…

HTZ $684M

Jimmy's Journal Oct 26 69 clicks

Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3

Avalo Therapeutics' Abdakibart enters a pivotal hidradenitis suppurativa trial after positive LOTUS data, with monthly dosing and…

AVTX $383M

Myriam Alvarez Oct 25 3 clicks

I went through all 142 companies in Value Line this morning. Here are the 6 that made it

Six Value Line small caps including Blackbaud, Marqeta, Ranger Energy and Definitive Healthcare trade on net cash, buybacks, low multiples…

RNGR $357M

Calvin Blissett Oct 24 81 clicks

Research & Analysis: ERock, Inc. (NYSE: EROC)

ERock’s modular microgrids bridge data-center power gaps years before grid interconnects, with Meta and Anthropic projects filling capacity…

EROC $402M

Monte Independent Investment Research Oct 23 11 clicks

BMBL 2026-10-21

Bumble is being taken private

Bumble agreed to a $6.05-per-share cash sale to Ithaca Holdings, 136% above its October 2 share price.

BMBL $788M

Modern Value Investing Oct 21 8 clicks

Sagimet Biosciences: The U.S. Acne Trial Is A Replication Exercise, Not A Discovery Bet

Sagimet Biosciences' denifanstat enters a fully funded U.S. acne registration trial after Phase 3 results, with SGMT trading below cash and…

SGMT $741M

Equity Eagle Oct 21 3 clicks

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $537M

Trade Ideas Flow Oct 19 21 clicks

Sell Eagle Point Credit Now - Match The Loss With Portfolio Gains To Lower Income Taxes

Eagle Point Credit's NAV is down 25% YTD and shares nearly 50%, while its expense ratio climbed to 9.21% despite a 25% yield.

ECC $348M

Anthony Cataldo Oct 19 5 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $327M

TSOH Investment Research Oct 19 18 clicks

LendingTree (NASDAQ: $TREE) – A Cyclical Comeback Story Priced as if the Cycle Never Turns

LendingTree derives roughly two-thirds of revenue from insurance and trades near 4 times expected adjusted earnings despite record revenue,…

TREE $394M

Substack von Philipp Oct 19 11 clicks

EVC · long

Entravision Communications

Entravision Communications, up fourfold year to date, is pitched as an undervalued growth business emerging from a troubled parent…

EVC $588M

Value Investors Club Jul 27

Gladstone Investment: High Dividend Increases And NAV Gains, But Very Risky

Gladstone Investment's 50% equity portfolio drove NAV and dividend gains, but five holdings make up 44.5% of fair value and heighten Level…

GAIN $603M

Stephen Nemo Oct 21 4 clicks

TSOH Weekly Roundup (10/16/2026)

Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.

BMBL $788M

TSOH Investment Research Oct 16 12 clicks

Problems at Dream Finders Homes (DFH)

Dream Finders Homes’ controlling owner borrowed against DFH stock before the homebuilder agreed to finance an acquisition with costly…

DFH $909M

Hunterbrook Oct 15 15 clicks

Park Aerospace: The Q2'27 Sell-Off Misreads a Sole-Source Defense Supplier

Park Aerospace’s 11% Q2’27 sell-off overlooks sole-source PAC-3 rocket-motor materials and A320neo engine composites, with missile capacity…

PKE $585M

Monte Independent Investment Research Oct 15 14 clicks

Private Equity Prints Multibaggers With This Pattern. No One is Talking About It.

Shenandoah Telecommunications’ Glo Fiber buildout ends this year, and private infrastructure investors’ repeated fiber deals frame a…

SHEN $523M

Phynvesting Oct 14 22 clicks

SED Energy: The 40% Dividend. Signal or Noise?

SED Energy's proposed Ventura merger projects a 22% to 40% dividend yield, but idle tender barges, debt and repayments materially reduce…

SBDXF $543M

Cannibal Stocks Oct 13 8 clicks

Monte Investments Market Brief Vol. CXXXI

Park Aerospace reported 27% revenue growth and 72% EPS growth, supported by composite materials for Airbus engines and PAC-3 rocket motors.

PKE $585M

Monte Independent Investment Research Oct 13 5 clicks

H&R REIT, an opportunity in a corrupt process

H&R REIT's proposed GO Residential transaction faces investor opposition over rejected $12.50 cash bids, insider benefits and tax…

GONYF $499M

Nugget Capital Partner's Substack Oct 12 2 clicks

Helus Pharma: A Buy Ahead Of The HLP003 Phase 3 Readout

Helus Pharma's HLP003 Phase 3 depression data is due in 4Q26, with $166.4 million in cash and dilution risk from a $100 million ATM…

HELP $615M

Petri Dish Reports Oct 11 3 clicks

Thursday, October 29, 2026

Barbarian Capital on X

Adam D. Wyden on X

A Capital on X

Myles on X

KEDM.com on X

DOMO Capital Management, LLC on X

Asif Suria on X

DOMO Capital Management, LLC on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 269

X accounts we follow

Investor letters we follow

Sectors